A Resident Of VinUniversity’s Internal Medicine Program Participated In The APAAACI Congress In Manila, Philippines
In the last month of 2022, Nguyen Hoang Kim Han, a resident of VinUniversity’s Internal Medicine program, participated in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) Congress in Manila, Philippines. The theme of the Congress is “Evidence-Based Integrated Care in Allergy, Asthma, and Immunology: The New Frontiers”.
The scientific program was a well-woven combination of the most recent advances in the science, novel therapies, and practical clinical aspects in allergy asthma and clinical immunology, environmental factors such as pollution, climate change, and more targeting both clinicians and researchers across specialties working in this space.
At this conference, Kim Han had an oral presentation about “Autosomal recessive hyper-IgE syndrome (AR-HIES) due to DOCK8 deficiency: Effectiveness of omalizumab”. This is a rare primary immunodeficiency syndrome characterized by recurrent viral infections, atopic dermatitis, severe allergies, and early-onset malignancies. AR-HIES are mostly caused by homozygous or compound heterozygous loss-of-function mutations in the DOCK8 gene. Anti-IgE therapy with Omalizumab is a targeted treatment for this syndrome.